These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17667983)

  • 1. Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor.
    Chuang PY; Yu Q; Fang W; Uribarri J; He JC
    Kidney Int; 2007 Oct; 72(8):965-76. PubMed ID: 17667983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus.
    Chuang PY; Dai Y; Liu R; He H; Kretzler M; Jim B; Cohen CD; He JC
    PLoS One; 2011; 6(8):e23566. PubMed ID: 21858169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.
    Rüster C; Bondeva T; Franke S; Tanaka N; Yamamoto H; Wolf G
    Am J Nephrol; 2009; 29(6):538-50. PubMed ID: 19129693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression.
    Liebisch M; Bondeva T; Franke S; Daniel C; Amann K; Wolf G
    Kidney Int; 2014 Jul; 86(1):103-17. PubMed ID: 24476693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes.
    Rüster C; Bondeva T; Franke S; Förster M; Wolf G
    Nephrol Dial Transplant; 2008 Jul; 23(7):2179-91. PubMed ID: 18344241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products inhibit adhesion ability of differentiated podocytes in a neuropilin-1-dependent manner.
    Bondeva T; Wojciech S; Wolf G
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F852-70. PubMed ID: 21734098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The receptor of advanced glycation end products plays a central role in advanced oxidation protein products-induced podocyte apoptosis.
    Zhou LL; Cao W; Xie C; Tian J; Zhou Z; Zhou Q; Zhu P; Li A; Liu Y; Miyata T; Hou FF; Nie J
    Kidney Int; 2012 Oct; 82(7):759-70. PubMed ID: 22622498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products.
    McRobert EA; Bach LA
    Nephrology (Carlton); 2016 Jan; 21(1):13-20. PubMed ID: 26032400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.
    Gu L; Hagiwara S; Fan Q; Tanimoto M; Kobata M; Yamashita M; Nishitani T; Gohda T; Ni Z; Qian J; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2006 Feb; 21(2):299-313. PubMed ID: 16263740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes.
    Zhu P; Ren M; Yang C; Hu YX; Ran JM; Yan L
    Exp Dermatol; 2012 Feb; 21(2):123-9. PubMed ID: 22229442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.
    Sharaf H; Matou-Nasri S; Wang Q; Rabhan Z; Al-Eidi H; Al Abdulrahman A; Ahmed N
    Biochim Biophys Acta; 2015 Mar; 1852(3):429-41. PubMed ID: 25514746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEDF inhibits AGE-induced podocyte apoptosis via PPAR-gamma activation.
    Ishibashi Y; Matsui T; Ohta K; Tanoue R; Takeuchi M; Asanuma K; Fukami K; Okuda S; Nakamura K; Yamagishi S
    Microvasc Res; 2013 Jan; 85():54-8. PubMed ID: 23108227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end-products suppress neuropilin-1 expression in podocytes.
    Bondeva T; Rüster C; Franke S; Hammerschmid E; Klagsbrun M; Cohen CD; Wolf G
    Kidney Int; 2009 Mar; 75(6):605-16. PubMed ID: 19037249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth arrest specific 2-like protein 1 expression is upregulated in podocytes through advanced glycation end-products.
    Liebisch M; Bondeva T; Franke S; Hause S; Wolf G
    Nephrol Dial Transplant; 2017 Apr; 32(4):641-653. PubMed ID: 27638909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-κB signaling pathway.
    An X; Zhang L; Yao Q; Li L; Wang B; Zhang J; He M; Zhang J
    Mol Cell Endocrinol; 2018 Jul; 470():14-25. PubMed ID: 28478303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of metformin and irbesartan on advanced glycation end products (AGEs)-RAGE-induced proximal tubular cell injury.
    Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
    Pharmacol Res; 2012 Mar; 65(3):297-302. PubMed ID: 22100460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular cell death and inflammation with high-protein diet and diabetes.
    Meek RL; LeBoeuf RC; Saha SA; Alpers CE; Hudkins KL; Cooney SK; Anderberg RJ; Tuttle KR
    Nephrol Dial Transplant; 2013 Jul; 28(7):1711-20. PubMed ID: 23314315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
    J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis.
    Maeda S; Matsui T; Takeuchi M; Yamagishi S
    Diabetes Metab Res Rev; 2013 Jul; 29(5):406-12. PubMed ID: 23508966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.